Risk Stratification of Hepatocellular Carcinoma in Hepatitis B Virus e Antigen-Negative Carriers by Combining Viral Biomarkers
โ Scribed by Tseng, T.-C.; Liu, C.-J.; Chen, C.-L.; Yang, H.-C.; Su, T.-H.; Wang, C.-C.; Yang, W.-T.; Kuo, S. F.-T.; Liu, C.-H.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.
- Book ID
- 123615433
- Publisher
- University of Chicago Press
- Year
- 2013
- Tongue
- English
- Weight
- 721 KB
- Volume
- 208
- Category
- Article
- ISSN
- 0022-1899
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Some individuals who are chronically infected with hepatitis B virus (HBV) eventually lose hepatitis B surface antigen (HBsAg). Hepatocellular carcinoma (HCC) has been demonstrated to occur in a few patients after loss of HBsAg. Neither factors associated with loss of HBsAg nor the incidence of HCC
The age-specific prevalence of hepatitis B e antigen (HBeAg) and its antibody (anti-HBe) were studied by radioimmunoassay, and compared in a large series of patients with chronic hepatitis B virus (HBV) infection, including 268 asymptomatic carriers, 389 chronic hepatitis, 114 liver cirrhosis, and 2